Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold - Wikidata - awgldk - TriplyDB

Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold

Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold

http://www.wikidata.org/entity/Q26781354

about

Proton Pump Inhibitors Accelerate Endothelial Senescence Primed Polymorphonuclear Leukocytes (PMNLs) from Hemodialysis Patients Enhance Monocyte Transendothelial Migration.Extrarenal effects of FGF23.Proton-pump inhibitors: understanding the complications and risks.Predicting the Functionality and Form of a Dialysis Fistula.Sevelamer reduces endothelial inflammatory response to advanced glycation end products.Endothelial Dysfunction in Kidney Transplantation.

P2860

Q36993998-5FEE3409-C261-4CE3-82F8-28C7737676CF Q38646650-D8A5B5E2-8516-491A-902E-EDF88EE6B52B Q38972469-BBD4FF0C-21B3-45C7-AAF6-4F38B459448B Q41996131-1D64AF2D-2D32-48F7-BA0A-A17EBA33440C Q46220963-285CBCB9-FDDA-473E-9F30-C98AF5191FE8 Q48505037-D7EECB5C-AEFC-488B-A427-0A81DB032959 Q54983740-6264CB6A-7469-4211-A9F5-14AB9F19DAEE

P2860

Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold

http://www.wikidata.org/entity/Q26781354

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pathogenesis of endothelial ce ...... e and what the future may hold

@ast

Pathogenesis of endothelial ce ...... e and what the future may hold

@en

Pathogenesis of endothelial ce ...... e and what the future may hold

@nl

type

label

Pathogenesis of endothelial ce ...... e and what the future may hold

@ast

Pathogenesis of endothelial ce ...... e and what the future may hold

@en

Pathogenesis of endothelial ce ...... e and what the future may hold

@nl

prefLabel

Pathogenesis of endothelial ce ...... e and what the future may hold

@ast

Pathogenesis of endothelial ce ...... e and what the future may hold

@en

Pathogenesis of endothelial ce ...... e and what the future may hold

@nl

P1433

Q26781354-396D1BB4-8B65-4893-8484-6316FD0DB7F8

P1476

Q26781354-98AB9327-5CC4-42FC-BDCC-79EC73799357

P2093

Q26781354-1C395127-6FB9-4740-AA37-903B897B31C1

P2860

Q26781354-012BB653-3416-4875-96D4-E29F67645A4F

Q26781354-246892B2-D96E-4489-930A-181A0DFE93DA

Q26781354-2B5482E1-8249-49BA-A492-47A8FB1F7591

Q26781354-42B00033-257A-4CBF-8D08-FE7E1A65EC99

Q26781354-620FDA07-B251-49D4-8D7C-5AC38E3CA57B

Q26781354-646F81E0-2B51-4225-A2FD-409D31661F57

Q26781354-65FB154C-2798-4286-A816-A12788C2F13A

Q26781354-69E18059-54D1-4730-A961-4A08560D6514

Q26781354-7523BE83-60F6-43AE-AFDD-0E0CF7B18E2B

Q26781354-7ADB1B9B-5A45-4D52-96F7-9570597068FB

P304

Q26781354-81C81501-57DE-4ECD-A33C-647CC5DE466C

P31

Q26781354-A14DB962-5CF7-4E97-8C1F-5FF17A8CBEAA

P356

Q26781354-A4A02233-BDFA-41FD-A2A9-8BF143D7B29B

P407

Q26781354-D3B2792D-D95E-480F-BEFA-F28F95C25D01

P433

Q26781354-6ECE327E-D127-4331-9B50-6EB8A30674DF

P478

Q26781354-43E52766-30A0-4137-841D-FFD5295B6C23

P577

Q26781354-6B0D794B-7D0F-4C0E-A8C4-5430E6EB79C7

P5875

Q26781354-4BE8C20D-ABE9-49C5-A6A8-E8209CB4749A

P698

Q26781354-9583CFF6-A025-4F6C-8EAD-C388D8C61EFB

P921

Q26781354-28531E2E-E036-4630-B37B-0F0974430126

P932

Q26781354-06782B9B-18A5-4EDE-BF1E-60C50268E05A

P356

J.KRCP.2015.05.003

P1433

Kidney research and clinical practice

P1476

Pathogenesis of endothelial ce ...... e and what the future may hold

@en

P2093

Michael S Goligorsky

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of chronic kidney disease

Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure.

Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk.

Clinical assessment of endothelial dysfunction: combine and rule.

Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures.

The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach.

Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Bardoxolone methyl and kidney function in CKD with type 2 diabetes.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunction

P304

76-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.KRCP.2015.05.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277726949

http://www.w3.org/2001/XMLSchema#string

P698

26484026

http://www.w3.org/2001/XMLSchema#string

P921

P932

4570605

http://www.w3.org/2001/XMLSchema#string